Following identification of an unusual cluster of cases of malignant melanoma among laboratory employees at this national facility, several studies were done to provide further understanding and solutions to the problem. This paper discusses the Laboratory's response, including the educational campaign and institution of self-examinations. Experience with the melanoma surveillance program to date reinforces its validity.